Wataru Tomeno

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography

Kento Imajo, Takaomi Kessoku, Yasushi Honda et al. · Gastroenterology · 2015 · 807 citations · Full text

Medicine, Radiology, Diagnostic Imaging +16

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice

Yasushi Honda, Kento Imajo, Takayuki Kato et al. · PLoS ONE · 2016 · 170 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis

Yasushi Honda, Takaomi Kessoku, Yuji Ogawa et al. · Scientific Reports · 2017 · 128 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin

Yuji Ogawa, Kento Imajo, Yasushi Honda et al. · Scientific Reports · 2018 · 124 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study

Yasushi Honda, Takaomi Kessoku, Yoshio Sumida et al. · BMC Gastroenterology · 2017 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17